Search Results

Showing results 2091 - 2100 for weill cornell connect patient portal

Cell-based Assay for NRF2 Activators & NRF2 Activator Scaffolds as Neuroprotective/Antioxidant Agents | Enterprise Innovation

... Events Past Events Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/cell-based-assay-nrf2-activators-nrf2-activator

Modulating Adenylyl Cyclase for the Treatment of Bacterial or Eukaryotic Infections | Enterprise Innovation

... patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/modulating-adenylyl-cyclase-treatment-bacterial-or

Bacterial RNAs As Vaccine Adjuvants | Enterprise Innovation

... patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/bacterial-rnas-vaccine-adjuvants

Compositions and Methods for the Treatment and Prevention of Ulcerative Colitis and Colon Cancer and Screening Methods to Identify Same | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/compositions-and-methods-treatment-and-prevention

Protein Knockout Platform | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/protein-knockout-platform

Method to Promote Normal Brain Development and Decrease Risk for Psychiatric Disorders in Pre-adults with a Mutation in BDNF | Enterprise Innovation

... of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/method-promote-normal-brain-development-and

p21 Inducers as Neuroprotective and Anticancer Agents | Enterprise Innovation

.... Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/p21-inducers-neuroprotective-and-anticancer-agents

Compounds that Induce Arginase 1 to Enhance Neuroprotection | Enterprise Innovation

... Events Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/compounds-induce-arginase-1-enhance-neuroprotection

Blocking Leukocyte Migration and Inflammation with Antibodies | Enterprise Innovation

.... Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/blocking-leukocyte-migration-and-inflammation

myHelpdesk | Information Technologies & Services

... Senior Management Annual Reports Weill Cornell Medicine Care Discover Teach Home Get Help How-To News...

https://its.weill.cornell.edu/get-help/myhelpdesk

Showing results 2091 - 2100 for weill cornell connect patient portal